Browsing by Subject "Barthel index"

Now showing 1 - 5 of 5
  • No Thumbnail Available
    Item
    The efficacy of botulinum toxin A intramuscular injections in after-stroke spasticity; [İnme sonrasi gelişen spastisite tedavisinde botulinum toksin A i̇ntramusküler enjeksiyonu etkinliǧi]
    (2010) Karaçam M.; Selçuki D.
    Objective: Spasticity is a common dysfunction in stroke patients. It hinders the performance of everyday living activities and lowers the quality of life. In this study, it was aimed to investigate the effects of botulinum toxin A therapy on various aspects, such as muscle tone, pain, daily living activities and disability. Patients and Methods: Fifteen patients with stroke presenting with focal spasticity in the botulinum toxin outpatient unit were evaluated. Results before and after treatment were evaluated by applying different scales. Modified Ashworth Scale was applied for the severity of spasticity. The Medical Council Research Scale was used to test muscle power, and the disability scoring scale, Visual Analogue Pain Scale and Barthel index were the other measures tested. Results: It was found that therapy with botulinum toxin A was effective in spasticity. The increased muscle tone and the disability scores decreased prominently after the treatment (p< 0.05). Lower values in pain scores (p< 0.05) also contributed to better functional outcome (p< 0.01). Along with the significantly good outcome according to the scales, the higher scores in quality of life, feeling of well-being, good performance during the physiotherapy sessions, and less medications needed for spasticity were also indications in commencing the therapy of botulinum toxin A in spasticity. Conclusion: Spasticity is a complicated condition causing serious disability. Botulinum toxin A is a preferred therapy when there is an increased motor activity. The effects of the agent are reversible and reliable. The duration of the treatment is long-lasting. Since botulinum toxin A is easily applied and the outcome in focal spasticity is favorable, it is recommended as the first-line choice in the treatment of focal spasticity.
  • No Thumbnail Available
    Item
    Adaptation, reliability, and validity study of the hwalek–sengstock elder abuse screening test (H-S/EAST): A Turkish version
    (Turkiye Klinikleri Journal of Medical Sciences, 2017) Özçakar N.; Toprak Ergönen A.; Kartal M.; Baydur H.
    Background/aim: The most important issues in elder abuse and neglect are lack of awareness and difficulties in determining the situation. Our aim is to determine the reliability and validity of the Turkish version of the Hwalek–Sengstock Elder Abuse Screening Test (H-S/EAST). Materials and methods: The H-S/EAST (15-itemed, three-dimensional: direct abuse, characteristics of vulnerability, and potentially abusive situation) was translated according to the guidelines and experts evaluated it for content validity and cultural adaptation. Participants’ (n = 252) mean age was 73.4 ± 6.4 years and 58.3% were female. The World Health Organization Quality of Life Instrument-Older Adults Module (WHOQOL-OLD) and the Barthel Index were used for validity. Cronbach’s alpha for internal consistency, exploratory factor analysis for content validity, t-test for construct validity, and discriminant ability were used. SPSS 15.0 was used for analysis and statistical significance was P < 0.05. Results: In test–retest reliability, internal consistency coefficient values for direct abuse, characteristics of vulnerability, and potentially abusive situation were 0.88, 0.73, and 0.80, respectively. Cronbach’s alpha for internal consistency of the H-S/EAST was 0.741. Exploratory factor analysis obtained 5 factors, and explained variance was 61.8%. Cut-off value was 6, and sensitivity, specificity, and area under the ROC curve were 76.9%, 96.2%, and 0.938, respectively. Conclusion: The Turkish version of the H-S/EAST can be used as a reliable, valid clinical tool for the assessment of elder abuse. © TÜBİTAK.
  • No Thumbnail Available
    Item
    Best Practice Recommendations for Geriatric Dysphagia Management with 5 Ws and 1H
    (Korean Geriatrics Society, 2022) Umay E.; Eyigor S.; Bahat G.; Halil M.; Giray E.; Unsal P.; Unlu Z.; Tikiz C.; Vural M.; Cincin A.T.; Bengisu S.; Gurcay E.; Keseroglu K.; Aydeniz B.; Karaca E.C.; Karaca B.; Yalcin A.; Ozsurekci C.; Seyidoglu D.; Yilmaz O.; Alicura S.; Tokgoz S.; Selcuk B.; Sen E.I.; Karahan A.Y.; Yaliman A.; Ozkok S.; Ilhan B.; Oytun M.G.; Ozturk Z.A.; Akin S.; Yavuz B.; Akaltun M.S.; Sari A.; Inanir M.; Bilgilisoy M.; Çaliskan Z.; Saylam G.; Ozer T.; Eren Y.; Bicakli D.H.; Keskin D.; Ulger Z.; Demirhan A.; Calik Y.; Saka B.; Yigman Z.A.; Ozturk E.A.
    Background: Dysphagia is a geriatric syndrome. Changes in the whole body that occur with aging also affect swallowing functions and cause presbyphagia. This condition may progress to oro-pharyngeal and/or esophageal dysphagia in the presence of secondary causes that increase in incidence with aging. However, no study has been published that provides recommendations for use in clinical practice that addresses in detail all aspects of the management of dysphagia in geriatric individuals. This study aimed to answer almost all potential questions and problems in the management of geriatric dysphagia in clinical practice. Methods: A multidisciplinary team created this recommendation guide using the seven-step and three-round modified Delphi method via e-mail. The study included 39 experts from 29 centers in 14 cities. Results: Based on the 5W and 1H method, we developed 216 detailed recommendations for older adults from the per-spective of different disciplines dealing with older people. Conclusion: This consensus-based recommendation is a useful guide to address practical clinical questions in the diagnosis, rehabilita-tion, and follow-up for the management of geriatric dysphagia and also contains detailed com-mentary on these issues. © 2022 by The Korean Geriatrics Society.
  • No Thumbnail Available
    Item
    Demographic and clinical characteristics of inpatient stroke patients in Turkey
    (Turkish Society of Physical Medicine and Rehabilitation, 2022) Külcü D.G.; Kuran B.; Karahan A.Y.; Özgirgin N.; Başaran S.; Yalıman A.; Savaş S.; Tıkız C.; Aktaş İ.; Bardak A.; Tuncer T.; Yılmaz F.; Erhan B.; Şirzai H.; Çelik B.; Durlanık G.; Doğu B.; Öncü J.; Hüner B.; Öztürk G.; Eskiyurt N.; Akpınar F.M.; Özkan F.Ü.; Paker N.; Buğdaycı D.S.; Gündüz B.; Şatır Ö.; Atalay N.Ş.; Yıldız N.; Altındağ Ö.; Demir S.E.; Kaya E.; Uçar D.; Sarı A.; Karataş G.K.; Taşkıran Ö.Ö.
    Objectives: This study aims to assess the stroke rehabilitation facilities provided by university hospitals (UHs) and training and research hospitals (TRHs) and to evaluate the geographical disparities in stroke rehabilitation. Patients and methods: Between April 2013 and April 2014 a total of 1,529 stroke patients (817 males, 712 females; mean age: 61.7±14.0 years; range, 12 to 91 years) who were admitted to the physical medicine and rehabilitation clinics in 20 tertiary care centers were retrospectively analyzed. Demographic, regional and clinical characteristics, details of rehabilitation period, functional status, and complications were collected. Results: The median duration of stroke was five (range, 1 to 360) months. The ratio of the patients treated in the TRH in the Marmara region was 77%, but only 25% of the patients were living in the Marmara region. Duration of hospitalization was longer in the TRHs with a median of 28 days compared to those of UHs (median: 22 days) (p<0.0001). More than half of the patients (55%) were rehabilitated in the Marmara region. Time after stroke was the highest in the Southeast region with a median of 12 (range, 1 to 230) months and the lowest in the Aegean region with a median of four (range, 1 to 84) months. Conclusion: This study provides an insight into the situation of stroke rehabilitation settings and characteristics of stroke patients in Turkey. A standard method of patient evaluation and a registry system may provide data about the efficacy of stroke rehabilitation and may help to focus on the problems that hinder a better outcome. © 2022 All right reserved by the Turkish Society of Physical Medicine and Rehabilitation.
  • No Thumbnail Available
    Item
    Applying the WHO ICF framework to long COVID patients with persistent respiratory symptoms
    (Turkish Society of Physical Medicine and Rehabilitation, 2023) Köseoğlu B.F.; Tur B.S.; Gökkaya N.K.O.; Gökmen İ.G.; Kesiktaş F.N.; Kaya B.B.; Önal R.; Tuncay F.; Genç A.; Findikoglu G.; Doğan Ş.K.; Sütbeyaz S.T.; Sarıkaya S.; Tıkız C.; Özdemir H.; Kabayel D.D.; Atar M.Ö.; Atan T.; Yüksel S.
    Objectives: The aim of this study was to evaluate long COVID patients with persistent respiratory symptoms through the application of the World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) framework. Patients and methods: This national, prospective, multicenter, cross-sectional study was conducted with 213 patients (118 females, 95 males; median age 56 years; range, 20 to 85 years) with long COVID between February 2022 and November 2022. The ICF data were primarily collected through patient interviews and from the acute medical management records, physical examination findings, rehabilitation outcomes, and laboratory test results. Each parameter was linked to the Component Body Functions (CBF), the Component Body Structures (CBS), the Component Activities and Participation (CAP), the Component Environmental Factors (CEF), and Personal Factors according to the ICF linking rules. Analysis was made of the frequency of the problems encountered at each level of ICF category and by what percentage of the patient sample. Results: In the ICF, 21 categories for CBF, 1 category for CBS, and 18 categories of CAP were reported as a significant problem in a Turkish population of long COVID patients with persistent respiratory symptoms. Furthermore, eight categories for CEF were described as a facilitator, and four as a barrier. Conclusion: These results can be of guidance and provide insight into the identification of health and health-related conditions of long COVID patients with persistent respiratory symptoms beyond the pathophysiological aspects, organ involvement, and damage of COVID-19. The ICF can be used in patients with long COVID to describe the types and magnitude of impairments, restrictions, special needs, and complications. ©2023 All right reserved by the Turkish Society of Physical Medicine and Rehabilitation.